This inventor holds 1 USPTO granted patent. Top assignees: The University of British Columbia, University of California. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2009
Title: Micah Steffek: Innovator in Mycothiol Biosynthesis
Introduction
Micah Steffek is an accomplished inventor based in Simi Valley, California. He has made significant contributions to the field of biochemistry, particularly in the area of mycothiol biosynthesis. His innovative work has the potential to impact the treatment of bacterial infections in mammals.
Latest Patents
Micah Steffek holds a patent titled "Methods of use of the enzymes of mycothiol synthesis." This invention utilizes three families of bacterial enzymes that play a crucial role in mycothiol biosynthesis. The patent details the use of bacterial cysteine:glucosaminyl inositol ligases (MshC), bacterial acetyl-CoA:Cys-GlcN-Ins acetyltransferases (MshD), and bacterial MshA glycosyltransferase. The invention provides methods for using these enzymes in drug screening assays to identify compounds that inhibit their activity. It also outlines a treatment approach for actinomycete infections in mammals using antibiotics that target these enzymes, thereby reducing the virulence of the infecting bacteria. Additionally, the patent includes a live mutant with a modified genome and an expression vector comprising polynucleotides of mshA, mshB, mshC, and mshD.
Career Highlights
Throughout his career, Micah has worked with prestigious institutions such as the University of California and the University of British Columbia. His research has focused on the biochemical pathways involved in mycothiol synthesis and their implications for antibiotic development.
Collaborations
Micah has collaborated with notable colleagues, including Dipti Sareen and Gerald L. Newton. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Micah Steffek's innovative work in mycothiol biosynthesis represents a significant advancement in the field of biochemistry. His contributions have the potential to lead to new treatments for bacterial infections, showcasing the importance of research and innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile